Pantoprazole Sodium Tablet, Delayed Release
Product Images NDC 71610-653

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Pantoprazole Sodium (NDC 71610-653). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 40 mg (71610 0653 30)

Bottle Label 40 mg (71610 0653 30)
Label for Pantoprazole Sodium Delayed Release (DR) Tablets, USP 40 mg, containing 30 tablets. The label includes the NDC number 71610-0653-30 and states storage instructions between 20-25 degrees Celsius (68-77 degrees Fahrenheit) at controlled room temperature. It includes manufacturer details: Evantic Pharmaceuticals Inc., Hauppauge, NY, and repackager Aphena Pharma, Cookeville, TN. The label is marked for prescription use only (RX Only).*
FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Structure.jpg (Structure)

Structure.jpg (Structure)
Chemical structure of pantoprazole, showing its molecular components including fluorinated benzene ring, sulfoxide group, methoxy-substituted pyridine ring, and hydrate form as indicated by 1.5 H2O.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.